What Should We Use for the Functional Assessment of Coronary Lesions in Severe Aortic Stenosis?

This systematic analysis measured intracoronary pressure in different phases of the cardiac cycle and flow velocity in patients with severe aortic stenosis and coronary artery disease, who were scheduled for transcatheter aortic valve replacement (TAVR). The aim was to determine the impact of aortic stenosis on: 1) flow, at different phases; 2) hyperemic coronary flow; 3) fractional flow reserve (FFR) and instantaneous wave-free ratio (iFR) measurements (the most commonly used tools in clinical practice to define stenosis severity).

¿Qué usar para medir funcionalmente una lesión coronaria en el contexto de estenosis aórtica severa?A significant proportion (up to half) of patients with severe aortic stenosis have concomitant coronary artery disease. The effect of valve disease on flow, coronary pressure, and the established clinical indices of stenosis is yet to be studied.

 

This work included 28 patients with 30 lesions, in whom intracoronary pressure and flow assessments were performed at rest and during hyperemia immediately before and after TAVR.


Read also: Safety of Lesion Deferral with iFR or FFR in Both Stable and Acute Patients.


Flow during the wave-free period of diastole did not change significantly after TAVR (29.78 ± 14.9 cm/s vs. 30.81 ± 19.6 cm/s; p = 0.64), unlike whole-cycle hyperemic flow, which increased significantly after the procedure (33.44 ± 13.4 cm/s pre-TAVR vs. 40.33 ± 17.4 cm/s post-TAVR; p = 0.006). The latter was secondary to an increase in systolic hyperemic flow after TAVR.

 

iFR values did not change after aortic valve replacement (0.88 ± 0.09 pre-TAVR vs. 0.88 ± 0.09 post-TAVR; p = 0.73), unlike FFR values, which decreased significantly after TAVR (0.87 ± 0.08 pre-TAVR vs. 0.85 ± 0.09 post-TAVR; p = 0.001). In consequence, we finally have a reliable tool (iFR) for the invasive assessment of intermediate lesions in severe aortic stenosis.

 

Conclusion

Both systolic and hyperemic coronary flow increase significantly after TAVR, so that hyperemic indices including systole (FFR) underestimate the severity of coronary stenosis in patients with severe aortic stenosis.


Read also: SOLACI-SOCIME 2018 | Usefulness of the functional evaluation with iFR and FFR in bifurcations to define PCI.


Flow during the wave-free period of diastole does not change, which suggests that measurements taken during this specific period (iFR) are not vulnerable to confounding effects or changes caused by aortic valve stenosis. For these patients, iFR seems to be the standard.

 

Original title: Coronary Hemodynamics in Patients with Severe Aortic Stenosis and Coronary Artery Disease Undergoing Transcatheter Aortic Valve Replacement Implications for Clinical Indices of Coronary Stenosis Severity.

Reference: Yousif Ahmad et al. J Am Coll Cardiol Intv 2018, article in press.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

TCT 2024 | FAVOR III EUROPA

The study FAVOR III EUROPA, a randomized trial, included 2,000 patients with chronic coronary syndrome, or stabilized acute coronary syndrome, and intermediate lesions. 1,008...

TCT 2024 | TRISCEND II

This randomized study included 400 patients; 267 were treated with EVOQUE valve and 133 with optimal medical treatment (OMT). After one-year follow-up, there were no...

TCT 2024 – ACCESS-TAVI: Comparing Percutaneous Access Closure Strategies After TAVI

Vascular access complications following transcatheter aortic valve implantation (TAVI) remain common. However, few studies compare vascular access closure methods.  Based on the CHOICE-CLOSURE and MASH...

TCT 2024 – ECLIPSE: Randomized Study of Orbital Atherectomy vs Conventional PCI in Severely Calcified Lesions

Coronary calcification is associated with stent under-expansion and increased risk of both early and late adverse events. Atherectomy is an essential tool for uncrossable...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

TCT 2024 | FAVOR III EUROPA

The study FAVOR III EUROPA, a randomized trial, included 2,000 patients with chronic coronary syndrome, or stabilized acute coronary syndrome, and intermediate lesions. 1,008...

TCT 2024 | TRISCEND II

This randomized study included 400 patients; 267 were treated with EVOQUE valve and 133 with optimal medical treatment (OMT). After one-year follow-up, there were no...

TCT 2024 – ACCESS-TAVI: Comparing Percutaneous Access Closure Strategies After TAVI

Vascular access complications following transcatheter aortic valve implantation (TAVI) remain common. However, few studies compare vascular access closure methods.  Based on the CHOICE-CLOSURE and MASH...